BOSTON, MA AND SAN FRANCISCO, CA / ACCESS Newswire / December 15, 2025 / Access Advance LLC and Via Licensing Alliance announced today Access Advance's acquisition of Via's HEVC/VVC program, a move ...

This week, the House unanimously passed the bipartisan Hospital Inpatient Services Modernization Act (HR4313), also known as the hospital-at-home bill. This bill, which was introduced by Republican ...

Editor’s note: This is the second story in a collaborative series covering the state of Northwest college admissions in 2025. It was reported and edited by OPB news partners KUOW and Northwest Public ...

TAMPA, Fla. (WFLA) — Tampa International Airport announced its All Access program returns Monday, allowing guests who aren’t traveling on a flight to visit any of TPA’s four Airside terminals, where ...

STARKVILLE, Miss.—Mississippi State’s Jordan Spencer is now the director of the university’s ACCESS Program and Specialized College Services, a new unit that expands MSU’s support to students with ...

Pennsylvania is modernizing its Hunter Access Program to improve transparency for hunters and landowners. A new online portal will feature a three-tiered system for private land access, with some ...

While artificial intelligence has become ubiquitous in national education debates, access to AI literacy programs remains uneven, especially in some rural and Indigenous communities where ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

Christopher Palma does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Christian Olaniran is a digital producer for CBS Baltimore, where he writes stories on diverse topics including politics, arts and culture. With a passion for storytelling and content creation, he ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...